Joshua Muia: Our Latest Review on the Proatherogenic Metalloprotease ADAMTS7
Joshua Muia, Associate Investigator at Versiti Blood Research Institute, shared on LinkedIn about a recent article he and his colleagues co-authored, adding:
”Thrilled to share our newly published review on the proatherogenic metalloprotease ADAMTS7!
Proud of the incredible effort by trainees in my lab, working together with medical students and postdoctoral fellows across Oklahoma State University Center for Health Sciences, National Eye Institute (NIH), Georgetown University Medical Center, and Versiti Blood Research Institute.”
Title: The biology and pathophysiology of the proatherogenic metalloprotease ADAMTS7
Authors: Shiwali Goyal, James Muniu, Mohd Akbar Bhat, Eli Oldham, Derrick Pruitt, Luis Frias Perez, Frida Miranda, Joshua Muia
Read the Full Article on Open Biology
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 3, 2026, 05:55New Evidence Supports Chromogenic Assays After Hemophilia A Gene Therapy – JTH
-
Jul 3, 2026, 05:50Jacopo Parizzi: Roche’s Non-Malignant Hematology Team Is Looking Ahead to 2027
-
Jul 3, 2026, 05:25Brian A Beh: A New Approach from The George Institute for Global Health Could Transform Stroke Care Before Hospital Arrival
-
Jul 3, 2026, 05:22Deirdre Finnigan: New Insights into Red Blood Cell Biomechanics in Cancer-Associated Anemia
-
Jul 3, 2026, 05:15Danielle Boyle: Collaboration Across Borders Is Helping Shape the Future of ITP Care
-
Jul 3, 2026, 05:05Claire McIvor: One Year at the Stroke Association and Grateful for a Workplace That Made It Possible
-
Jul 2, 2026, 23:11Michael Makris: Join The Cancer Associated Thrombosis Workshop at ISTH 2026
-
Jul 2, 2026, 21:54Rob Maloney: Rare Disease Requires Relational Care
-
Jul 2, 2026, 21:53Quintijn Bonnez: How ADAMTS13 Conformation May Predict Early Relapse and Guide Pre-Emptive Therapy